Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
Plus
27
แน13782101
65%
chance
1D
1W
1M
ALL
Resolves YES if there is reliable public evidence of this happening. Resolves NO 10 years after Donald Trump dies in case information comes out after his death.
Get แน1,000 play money
Related questions
Related questions
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
39% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
81% chance
Will a junk/fast food company use engineered additives to mitigate the effects of GLP-1 agonists (Ozempic)?
11% chance
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
42% chance
Nobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
25% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
15% chance
Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?
71% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance